MENU
ARDX
AS OF
Nov 19, 04:59 PM (EDT)
Price
$5.57
Change
-$0.24 (-4.13%)
Capitalization
1.41B
112 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ARDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Ardelyx (ARDX) Ownership - Who owns Ardelyx?

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.41B
P/E Ratio
N/A
Total Cash
242.71M
Projected Growth
N/A
Total Debt
207.61M
Revenue
398.23M
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash/Share
1.00
Total Debt/Equity
N/A
Revenue/Share
1.66 USD as % of share price

Fundamentals

ARDX
Capitalization
1.41B
P/E Ratio
N/A
Risk (Beta)
0.18
Dividend Yield
N/A
Total Cash
243M
Total Cash/Share
1.00
Total Debt
208M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.66%
Revenue
398M
ROE
N/A
Book Value
154M
P/B Ratio
9.12
Cash Flow
N/A
Earnings
-0.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
24K
Current Ratio
4.41
Current Revenue Per Employee
279313.94
Dividends Per Share - Security
N/A
EBITDA
-26.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
96.39
Revenue To Assets
-13.24
Shares Held By Institutions
1.18B
Shares Outstanding - Current
243M
Total Liabilities
332M
Total Volume MTD
N/A
Value
-1
Gain YTD
14.201
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ARDX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARDX showed earnings on October 30, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ARDX
A.I. Advisor
published General Information

General Information

a developer of therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
400 Fifth Avenue
Phone
+1 510 745-1700
Employees
267
Web
https://www.ardelyx.com